GHK‑Copper is a tiny three‑amino‑acid peptide that binds copper with high affinity. Dr. Jason Schuster explains that its ability to rewrite gene activity gives it potent anti‑cancer and anti‑aging potential.
Tripeptide with Copper Affinity
GHK (glycine‑histidine‑lysine) is a naturally occurring tripeptide. Its structure gives it a strong affinity for copper ions, creating the GHK‑Copper complex that has been studied for hair loss, skin repair, lung, liver, bone and nervous tissue health.
- Glycine (G) – histidine (H) – lysine (K) composition
- High‑affinity binding to copper (Cu²⁺)
- Found in skin‑care formulations and endogenous plasma
Gene Expression Modulation
According to Dr. Schuster, GHK‑Copper can down‑regulate oncogenic pathways. In metastatic colon cancer models it reversed the expression of roughly 70 % of the over‑active genes. It also raises basic fibroblast growth factor (BFGF) and vascular endothelial growth factor (VEGF), promotes macrophage migration, and supports collagen synthesis for tissue remodeling.
- Reverses 70 % of a metastatic colon cancer gene signature
- Increases BFGF and VEGF to stimulate vascular growth
- Stimulates macrophage and white‑blood‑cell migration
- Enhances collagen production and osteoblastic activity
Anti‑Cancer and Regenerative Effects
Dr. Schuster notes that GHK‑Copper’s gene‑modulating action translates into broad health benefits: suppression of cancer‑related genes, accelerated hair regrowth, skin rejuvenation, bone healing, and improved mitochondrial ATP production. The peptide is considered safe and well‑tolerated across multiple studies.
- Down‑regulates cancer‑promoting genes
- Supports hair regrowth and skin elasticity
- Promotes bone and liver tissue repair
- Boosts mitochondrial function and ATP output
Practical Administration
Clinical protocols cited by Dr. Schuster include a topical spray or dropper delivering 5 mg per day for hair loss (effects observed after about three months) and sub‑cutaneous injections of 2.5 mg three times weekly for systemic benefits. He emphasizes that the peptide is very safe and does not appear to fuel existing cancers.
- Topical: 5 mg daily, ~3 months for hair results
- Injectable: 2.5 mg SC three times per week
- Well‑tolerated, no reported cancer promotion
“GHK reverses the expression of about 70 % of the genes driving metastatic colon cancer.”— Dr. Jason Schuster
Dr. Schuster's short takes on this topic — tap to play.
Go deeper than the summary
Dr. Schuster's accredited courses on supplementation, epigenetics, and peptide therapy — the full research, dosing, and video breakdowns.